# approved_drugs
Track hit to lead campaigns of all approved small molecules

![Alt text](image.png?raw=true )


## List

### 2019

 - alpelisib (Piqray; Novartis)
 - erdafitinib (Balversa; Astex -> Janssen)
 - darolutamide (Nubeqa; Orion -> Bayer) 
 - fedratinib (Inrebic; TargeGen -> Sanofi -> Celgene)
 - selinexor (Xpovio; Karyopharm Therapeutics)
 - entrectinib (Rozlytrek; Roche)

### 2018

 - glasdegib (Daurismo; Pfizer)
 

